Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Josefien Knoeff to speak at Tackling Antimicrobial Resistance conference in London

On 17 September, Josefien Knoeff, Researcher at the Access to Medicine Foundation, will join at the Tackling Antimicrobial Resistance conference in London. The event, hosted by the Royal Society of Chemistry, will bring together experts from governments, regulatory bodies and academic institutions to discuss the growing problem of antimicrobial resistance (AMR) and potential solutions.

Date

17 September 2018

Josefien will present the key findings of the first-ever AMR Benchmark, which shows how large research-based pharmaceutucal companies, generic medicine manufacturers and biopharmaceutical firms are addressing AMR and where further action is needed. Currently, the Access to Medicine Foundation research team is working on the metrics for the next AMR Benchmark that will be published in 2020.

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved